The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
Abstract
An analysis of return on investment can help policy makers support, optimize, and advocate for the expansion of immunization programs in the world's poorest countries. We assessed the return on investment associated with achieving projected coverage levels for vaccinations to prevent diseases related to ten antigens in ninety-four low- and middle-income countries during 2011-20, the Decade of Vaccines. We derived these estimates by using costs of vaccines, supply chains, and service delivery and their associated economic benefits. Based on the costs of illnesses averted, we estimated that projected immunizations will yield a net return about 16 times greater than costs over the decade (uncertainty range: 10-25). Using a full-income approach, which quantifies the value that people place on living longer and healthier lives, we found that net returns amounted to 44 times the costs (uncertainty range: 27-67). Across all antigens, net returns were greater than costs. But to realize the substantial positive return on investment from immunization programs, it is essential that governments and donors provide the requisite investments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The value of a statistical life: A critical review of market estimates throughout the world
Viscusi, W. K., & Aldy, J. E. (2003) · Journal of Risk and Uncertainty · doi:10.1023/a:1025598106257 · Cited by 2,135
Global Illness and Deaths Caused by Rotavirus Disease in Children
Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A., & Glass, R. I. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0905.020562 · Cited by 1,898
Global health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220
[Global health 2035: a world converging within a generation].
Jamison, D. T. T., Summers, L. H., Alleyne, G. A. O., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., EVANS, D. B., Feachem, R. G., Frenk, J. M., et al. (2015) · PubMed · Cited by 943
Global estimate of the incidence of clinical pneumonia among children under five years of age.
Rudan, I., Tomašković, L., Boschi-Pinto, C., & Campbell, H. J. (2004) · Europe PMC (PubMed Central) · Cited by 497
Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A. M., Temmerman, M., Mason, E., Friedman, H. S., Bhutta, Z. A., Lawn, J. E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62231-x · Cited by 355
Ozawa, S., Mirelman, A., Stack, M. L., Walker, D. G., & Levine, O. S. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.103 · Cited by 254
Self-citationBloom, D. E., Canning, D., & Weston, M. (2017) · Fighting the Diseases of Poverty · doi:10.4324/9780203791950-8 · Cited by 238
Lee, L. A., Franzel, L., Atwell, J., Datta, S. D., Friberg, I. K., Goldie, S. J., Reef, S. E., Schwalbe, N., Simons, E., Strebel, P. M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.11.035 · Cited by 181
Self-citationSingle versus multi-dose vaccine vials: An economic computational model
Lee, B. Y., Norman, B. A., Assi, T.-M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.048 · Cited by 107
Costs of vaccine programs across 94 low- and middle-income countries
Portnoy, A., Ozawa, S., Grewal, S. K., Norman, B. A., Rajgopal, J., Gorham, K. M., Haidari, L. A., Brown, S. T., & Lee, B. Y. (2015) · Vaccine · doi:10.1016/j.vaccine.2014.12.037 · Cited by 90
Self-citationStack, M. L., Ozawa, S., Bishai, D. M., Mirelman, A. J., Tam, Y., Niessen, L. W., Walker, D. G., & Levine, O. S. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0382 · Cited by 82
Self-citationThe willingness to pay for health changes, the human-capital approach and the external costs
Johannesson, M. (1996) · Health Policy · doi:10.1016/0168-8510(96)00815-9 · Cited by 73
Economic evaluation of pneumococcal conjugate vaccination in The Gambia
Kim, S., Lee, G. T., & Goldie, S. J. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-260 · Cited by 72
Ozawa, S., Stack, M. L., Bishai, D. M., Mirelman, A. J., Friberg, I. K., Niessen, L. W., Walker, D. G., & Levine, O. S. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0381 · Cited by 63
Self-citationEconomic Value of Dengue Vaccine in Thailand
Lee, B. Y., Connor, D. L., Kitchen, S. B., Bacon, K. M., Shah, M., Brown, S. T., Bailey, R. R., Laosiritaworn, Y., Burke, D. S., & Cummings, D. A. T. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0624 · Cited by 61
Health and economic impact of rotavirus vaccination in GAVI-eligible countries
Kim, S., Sweet, S., Slichter, D., & Goldie, S. J. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-253 · Cited by 58
Sinha, A., Constenla, D. O., Valencia, J. E., O’Loughlin, R. E., Gomez, E., de la Hoz, F., Valenzuela, M. T., & de Quadrós, C. A. (2008) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892008001100002 · Cited by 54
Bishai, D. M., Johns, B., Nair, D., Nabyonga‐Orem, J., Fiona-Makmot, B., Simons, E. A., & Dabbagh, A. J. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir131 · Cited by 45
Valuing vaccines: Deficiencies and remedies
Bloom, D. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.023 · Cited by 34
Cited by
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Simply put: Vaccination saves lives
Orenstein, W. A., & Ahmed, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704507114 · Cited by 446
Novel approaches for vaccine development
Gebre, M. S., Brito, L. A., Tostanoski, L. H., Edwards, D. K., Carfi, A., & Barouch, D. H. (2021) · Cell · doi:10.1016/j.cell.2021.02.030 · Cited by 347
Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32657-x · Cited by 300
Immunization: vital progress, unfinished agenda
Piot, P., Larson, H. J., O’Brien, K. L., N’kengasong, J., Ng, E., Sow, S., & Kampmann, B. (2019) · Nature · doi:10.1038/s41586-019-1656-7 · Cited by 206
Metadata
- Authors
- Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2016-02
- Volume
- 35
- Issue
- 2
- Pages
- 199-207
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2267348261
- Cited by
- 371
- References
- 20
- FWCI
- 61.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.